IL6R and rheumatoid arthritis: Repeated analysis with another exposure-related GWAS dataset also indicated that IL6R inhibitors could have a positive effect on the treatment of RA (OR: 0.994, 95% CI: 0.991–0.997, P = 3.47 × 10−5; Figure 2 and Supplementary Table S4).